“ I enjoy partnering with clients and offering them useful solutions to help them drive their businesses forward.
Lucy is a partner of Morrison & Foerster (International) LLP. Lucy’s practice focuses on a broad range of PRC–related corporate matters, including mergers and acquisitions, foreign direct investment, private equity, corporate restructuring, and general corporate matters. She also has extensive experiences in PRC real estate, regulatory, and employment issues.
Lucy regularly represents multinational corporations and financial institutions on their entering into the China market. She has also advised on some high–profile IPOs involving PRC companies’ listing in Hong Kong. Lucy has recently represented a number of Chinese companies on their overseas investments and acquisitions.
Prior to joining MoFo, Lucy was a national partner at the Beijing office of an international law firm. Prior to that, she worked at other top–tier international law firms (mainly Hong Kong offices) for more than 10 years.
Lucy is fluent in English, Mandarin, and Cantonese.
Represented this PRC state–controlled manufacturing company listed on the Shanghai Stock Exchange on its acquisition of a majority stake in the soft trim and acoustics business owned by IAC, under which more than 20 entities in more than 10 countries, including the United States, Germany, the UK, Mexico, Spain, Belgium, and South Africa, were acquired.
Represented this entity on its proposed acquisition of stakes in an Indonesia coal–production company.
Represented this entity in connection with (1) the sale of its stakes in Ganji.com (a major online local–services marketplace platform in China), for which the consideration consisted of cash and shares of 58.com, which is listed on the New York Stock Exchange; and (2) its investment in a Shenzhen startup company conducting research and sale of robots and AI machines.
Represented this entity on its strategic investment in Tiger Brokers, an online stock brokerage established for global Chinese retail and institutional clients.
Represented this entity on its establishment of several equity joint ventures with a PRC company owned by a PRC PE fund in Shanghai to manufacture medical devices and on the negotiation of the relevant licensing contracts.
Represented this entity with operation in China through VIE structure on the sale of its business in China to a well–known PE fund.
Represented this entity on its loan of HKD1.6 billion obtained from a HK assets management company and the related security arrangements, including a pledge of equity rights in PRC companies.
Represented this entity on various M&A transactions in LNG/LPG, real estate, jewelry, and insurance sectors.
Represented this entity in connection with its acquisition of a German medical–devices company.
Represented this entity on the sale of its shares in a Dutch company active in the sale and purchase of waste paper and used plastics, etc., to a HK subsidiary, wholly owned by a PRC‑listed company.
Represented this entity on its proposed acquisition of a minority stake in a French–listed game company.
Represented this entity on its proposed acquisition of the entire stake in a Luxemburg life insurance company.
Represented this entity mainly operating in China on its restructuring, including the repurchase of existing preference shares and the issuance of new preference shares of the Cayman company.
Represented this entity on its sale of certain automotive business operation around the world to a PRC Company.
Represented this entity on the privatization of a NYSE–listed chemical company operating in China.
Represented this entity on its establishment of a contractual joint venture in China with a PRC‑listed company to manufacture drugs and on the negotiation of the relevant licensing contracts.
Represented this entity on its acquisition of certain equity interest in a Sino–foreign fund management company from a state–controlled PRC company so that it could become the majority shareholder.
Represented this entity in connection with its purchase of a global coatings business, including several subsidiaries in China from a well–known coatings enterprise and the relevant China‑related financing/pledge matters.
Represented this entity on its sale of a broadband network and IDD businesses to a company formed by CVC Funds.
Represented this entity on its successful bid with a Thai company to acquire an Asian glass manufacturer operating in Malaysia, Vietnam, Thailand, and China from a Malaysian company, as well as on the restructuring of its various subsidiaries including WFOEs and joint ventures in China.
Represented this entity on its acquisition of a Chinese agricultural machinery manufacturer.
Represented this entity on the relevant PRC security arrangements including, among others, the assignment of rights and interest in a production–sharing contract (“PSC”) related to the exploitation of coalbed methane resources in China and a pledge of the receivables to be obtained by the borrower’s wholly owned subsidiary under the PSC.
Represented this entity on its US$50 million loan obtained from a HK lender and the relevant security arrangements, including a BVI/Cayman/PRC company share charge, personal guarantee, account charge, etc.
Represented this entity in connection with its production–sharing contract with a Chinese coal company.
Represented this entity in connection with its acquisition of a Chinese north–western wind power company.
Represented this entity in its bid for some stake in the Shenzhen municipal water supply company and in connection with the conclusion of separate concession arrangements for water supply and wastewater treatment in its other projects.
Represented this entity based in Finland on its asset–based financing matters especially on PRC‑related security issues and foreign debt issues.
Represented this entity of end–to–end InfiniBand and ethernet interconnect solutions and services for servers and storage on its establishment of a wholly owned subsidiary in China and on this subsidiary’s various employment issues, including the registration with SAFE, the employee incentive plans, and other regulatory issues.
Represented these companies (in particular Ogilvy & Mather) on a number of M&A and FDI transactions in the advertising, market survey, and marketing consultation industries in China.
Represented this entity on its investment into China’s health insurance sector.
Represented this entity on its initial public offering and listing on the Hong Kong Stock Exchange.
Represented this entity in its initial public offering and listing on the Hong Kong Stock Exchange.